{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG" in comments (approximate match)
Status:
Investigational
Source:
NCT03703505: Phase 1 Interventional Completed Healthy Volunteers
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00418795: Phase 2/Phase 3 Interventional Completed Acute Intermittent Porphyria
(2003)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03719586: Phase 2/Phase 3 Interventional Completed Ebola Virus
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:porgaviximab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02564744: Phase 2 Interventional Completed Diffuse Large B-Cell Lymphoma
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02410356: Phase 3 Interventional Terminated Growth Hormone Deficiency
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00351767: Phase 2 Interventional Completed Foot Ulcer, Diabetic
(2006)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03708224: Phase 2 Interventional Recruiting Cancer
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03943290: Phase 2 Interventional Terminated Facioscapulohumeral Muscular Dystrophy
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00284804: Phase 2 Interventional Completed Hodgkin's Disease
(2005)
Source URL:
Class:
PROTEIN
